Another baby formula shipment from Europe to arrive in the U.S. on Wednesday

Another baby formula shipment from Europe to arrive in the U.S. on Wednesday


Empty shelves show a shortage of baby formula at a Target store in San Antonio, Texas, May 10, 2022.

Kaylee Greenlee Beal | Reuters

FedEx Express has secured a government contract to bring another shipment of infant formula to the U.S. on Wednesday, NBC News reported.

The Express plane will fly Nestlé baby formula from Ramstein Air Base in Germany to Dulles International Airport near Washington, D.C. From there, the formula will be transported to a Nestlé facility in Pennsylvania. It’s unclear how much formula the plane will carry.

The move is meant to address a critical shortage of baby formula in the United States after top formula maker Abbott Laboratories closed a manufacturing plant following reports of bacterial infections in four infants.

Abbott said it would take about two weeks to reopen the plant and up to eight weeks for products to hit the shelves nationwide. That’s left a wide gap for scores of parents across the nation.

In an effort to ease the burden, the Food and Drug Administration is increasing baby formula imports from other countries. Dubbed “Operation Fly Formula,” the first shipment, carrying 78,000 pounds of specialty infant formula, arrived Sunday.

President Joe Biden has also invoked the Defense Production Act to increase baby formula manufacturing. His administration is seeking to stock shelves with 1.5 million containers of Nestle specialty infant formula.



Source

CDC takes down more than a dozen webpages on sexual and gender identity, health equity
Health

CDC takes down more than a dozen webpages on sexual and gender identity, health equity

A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters More than a dozen pages on the Centers for Disease Control and Prevention website related to sexual and gender identity, health equity, and other […]

Read More
We’re buying the dip in a health and life sciences stock that has gone down enough
Health

We’re buying the dip in a health and life sciences stock that has gone down enough

We’re buying 20 more shares of Danaher at roughly $180 each. Following Thursday’s trade, Jim Cramer’s Charitable Trust will own 470 shares of DHR, increasing its weighting to about 2.31% from about 2.22%. While Danaher has certainly been one of a handful of problematic stocks in the portfolio, we are stepping into the name here, […]

Read More
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
Health

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial

The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to […]

Read More